NASDAQ:IKNA
Delisted

Ikena Oncology Stock Signals

etoro logo Buy IKNA
*Your capital is at risk
$1.43
+0 (+0%)
At Close: Oct 24, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for Ikena Oncology, Inc.

General

Signal Type Signal Value Data
Score 0.000 63 days ( 0 %
Last Price $1.43 0 %
Performance History
7 Days
$1.43 $1.43
0%
30 Days
$1.43 $1.43
0%
12 Mos
$1.71 $1.43
-16.37%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $1.43 - $1.43
Trend - 3 mos -8.21 % High Width: 35,700.00 %
Pred. range - 3 mos $0.0404 - $14.46 Low -97.18 % - 911.16 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jul 28, 2025 - 64 days
RSI Short Pivot Signal Buy Very Low Aug 04, 2025 - 59 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 51.18
Signal Type Signal Value Importance Data
Trend - 12 mos -0.557 % Very High Width: 1,654.87 %
Pred. range - 12 mos $0.97 - $17.04 High -32.10 % - 1,091.60 %
Short MA 12 mos Buy Very High Jul 24, 2025 - 66 days
Long MA 12 mos Buy Very High Jul 24, 2025 - 66 days
Short/Long MA 12 mos Sell Very High Aug 22, 2025 - 45 days
Pivot Long Buy Low Jul 28, 2025 - 64 days
RSI Long Pivot Signal Buy Low Aug 11, 2025 - 54 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT IKENA ONCOLOGY, INC.
Ikena Oncology
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-1...
GOLDEN STAR
Ticker Change Signal Date
N
NXDR
$2.27
7.93% Aug 03
MC
$67.08
3.53% Jul 31
FCX
$62.63
10.79% Jul 31
ARW
$212.85
6.58% Jul 30
BIIB
$202.19
2.20% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE